for the development of resistance to /Mactams include (i) hydrolysis by /3-lactamases, (ii) creation of nonhydrolytic barriers by /?-lactamases, (iii) reduction in affinity of target proteins, and (iv) reduction in permeability2).
For Gramnegative enteric bacteria, the emergence of resistance to broad-spectrum penicillins and jS-lactamase-stable cephalosporins occurs frequently3). The complexity of (3-lactamase epidemiology has greatly increased with the emergence of extended-spectrum /3-lactamases (ESBLs) derived from plasmid-encoded TEM and SHV-type enzymes4). These /J-lactamases show greater specificity for /3-lactam antibiotics.
/3-Lactamases are divided by their substrates into classes A, B, C and D. Whenan isolate produces two different classes of /3-lactamases, the genes coding for each /3-lactamase are located separately on a plasmid and on a chromosome. For example, plasmid-encoded class A enzymes and chromosome-encoded class C enzymes are produced in Gram-negative bacteria. On the other hand, plasmid-encoded class B enzymes have been reported from Japan5). However, there are no reports of plasmids carrying the genes of two different classes of /Mactamases, such as class A and class B or class A and class D.
pp. 1135 -1139 In this report, we describe a novel plasmid carrying the genes for both class A and class B /3-lactamases in a clinical isolate of Serratia marcescens in Japan.
Materials and Methods

Test Organisms
The S. marcescens strain described here was isolated from the urine of a patient with a urinary tract infection at a hospital in northern Japan in 1996. 
Drug Susceptibility Assay
The susceptibility of the test strains to each drug was assayed in accordance with the specified drug sensitivity assay methods of the Japan Society of Chemotherapy except for the antibiotic concentrations used6). After overnight incubation at 35°C, medium containing organisms was diluted in buffered saline with gelatin to a concentration of 5~6X 106cfu/ml. Using a microplanter (Sakuma Seisakusho, Tokyo), aliquots of this suspension (about 5~6X104cfu/spot) were inoculated onto plates containing the test drug at various concentrations, and each plate was incubated for 18 hours at 35°C. The lowest concentration at which no bacterial growth was observed macroscopically was determined to be the minimum inhibitory concentration (MIC).
Characterization of Plasmids
For determination of incompatibility groups, the plasmid under study was introduced into E. coll K12 ML4901 together with a standard plasmid (previously grouped by conjugal transfer or transformation), and the incompatibility group of the test plasmid was determined as follows7). Organisms containing both the test plasmid and a standard plasmid of each incompatibility group were again incubated overnight in MHbroth at 35°C. This broth was then smeared on MHagar mediumand again incubated overnight at 35°C. The resulting colonies were collected and streaked onto plates containing a drug corresponding to the resistance pattern of the two plasmids, followed by further incubation overnight at 35°C. When organisms proliferated on both drug-containing plates, the test plasmid was considered to be of a different group from that of the DEC. 1999 standard plasmid. Whenorganisms proliferated on only one of the two plates, the test plasmid was considered to belong to the same incompatibility group as the standard plasmid. Analytical Isoelectric Focusing Isoelectric focusing was carried out with a Phast system (Pharmacia Biotech, Uppsala, Sweden) and a Phast Gel IEF 3-9 (Pharmacia Biotech). The enzyme protein on the gel plate was detected by staining with Coomassie brilliant blue G-250, and /?-lactamase activity was confirmed with nitrocefin ( 1 00 //g/ml).
Isolation of DNA
The procedures described in the manuals of Takara Suzo
Co., Otsu and in previous reports were followed for the isolation ofplasmid DNA9) Gene amplification was performed by a polymerase chain reaction (PCR) method using a commercially available PCR kit (Gene AmpPCRReaction Kit with Ampli TaqDNAPolymerase, Takara) and a DNAThermal denaturation at 94°C for 1 minute, annealing at 55°C for 1 minute, and elongation at 72°C for 1 minute, followed by heating at 72°C for 7 minutes. Five ji\ of the PCR product were subjected to electrophoresis on 1.2% agarose gel to identify the amplified DNAfragment.
Results and Discussion
The S. marcescens strain KU3838 that carries the plasmid described here was isolated from a patient with a urinary tract infection in November 1996 in Japan. E. coli KU3999was a transconjugant that served to transfer the conjugative plasmid from S. marcescens KU3838to E. coli K12 ML4901. The frequency of transfer by conjugation to E. coli K12 ML4901was about 1CT5 to 1(T6, and resistance to PIPC and IPM was transferred simultaneously as a single genetic unit, indicating that the plasmid-encoded class A and B /3-lactamases investigated in this study were transferable. This plasmid was designated pKU501. The incompatibility group of this plasmid was identified as 1137 previously described7). Whena donor pKU501culture was mixed with a recipient carrying plasmid S-a, which belongs to incompatibility group W, the resistance conferred by S-a was eliminated from the transconjugants by the newly introduced pKU501. In this case, resistance to both PIPC and IPMwas expressed in the recipient strain but the TC resistance mediated by S-a was lost. Therefore, class A and B /3-lactamase genes were confirmed to be located on the same plasmid, which belonged to incompatibility group W. carries both TEMtype and blam? type /3-lactamase genes. Enzyme activity was determined by spectrophotometry (UV2000, Shimadzu Corp.) at 30°C in 50mM phosphate buffer (pH 7.0) with or without lO^M ZnCl2, using antibiotics as the substrate. As a positive control, the enzyme activity of E. coli KU3991,which produces a plasmid-mediated class B /?-lactamase, was also determined. The activities of these /J-lactamases are shown in Table 3 . The enzyme from E. coli KU3999 had a broad substrate profile, hydrolyzed PCG, PIPC and CET frequently, and was inhibited by CVA. Moreover, when enzyme activity was assayed in the presence of CVA, hydrolysis of CTX, IPM, PAPM and MEPMbut not of AZT was still observed. These results suggested that DEC. 1999 pKU501 encodes both class A and B /3-lactamases. In addition, the enzyme activities against PAPM and MEPM were higher than against IPM, and substrate profiles of the enzyme encoded by pKU501were quite different from that of the enzyme produced by E. coli KU3991. These results reflected the MICs of IPM, PAPMand MEPM.The results showed that the activity of the enzyme encoded by pKU501 differed from that of the class B /J-lactamase reported in another study5). From these results, the class B /J-lactamase encoded by pKU501appears to be an extended-spectrum /?-lactamase.
We are now studying the genetic and molecular properties of pKU501. The DNA sequence analysis will be described elsewhere. The incidence of Gram-negative bacteria carrying blalMP was high in one hospital17), but low in another18). More rational and appropriate use of antibiotics can reduce the selective pressure for resistance mutations and the spread of resistance plasmids. In addition, controlling nosocomial infection is also very effective to limit to spread of resistance genes in these organisms.
In conclusion, we report a transferable plasmid carrying 
